Protein Alternatives

Protein Alternatives (PROALT) is a Spanish biotechnology company focused on the discovery and development of biomarkers and monoclonal antibodies for diagnostic and therapeutic use. The company's primary focus is on oncology, specifically colorectal cancer, where it has developed innovative blood-based diagnostic tools like the Colo-Fast kit. In addition to its internal R&D pipeline, PROALT provides specialized services to the life sciences industry, including custom recombinant protein expression and antibody production. Their lead therapeutic program involves monoclonal antibodies targeting Cadherin-17 for the treatment of advanced colorectal cancer.